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INTRODUCTION
Bovine mastitis has been estimated to cost the dairymen of
the United States 226 million dollars yearly - about 100 million
dollars more than any other disease of cattle (Poppensiek, I96O).
Of the many organisms capable of producing mastitis, StaphylO"
coccus aureus (S. aureus ) appeared to be most significant (Blobel
et al. , 1962a). Other authors have verified this fact by bacterio-
logical surveys. I4cCulloch (1946) found an incidence of Staphylo-
coccus in 64 percent of milk samples from 3»000 cows in northwest-
ern United States. A 50.9 percent incidence of Staphylococcic in-
fection was found in 3,137 milk saiaples from all over the United
States (Niksch et, al.
,
I96O). Galton (1961) in a six month sur-
vey of 1,010 milk samples discovered the presence of coag\ilase
positive staphylococci in 71 percent of the samples.
The advent of antibiotics not only failed to reduce the in-
fection rate due to S. aureus , but in all probability has increased
it by destroying the other bacterial flora in the mammary gland
and allowing the S. aureus to run rampant. The ability of the
staphylococci to develop rapid resistance to the various antibiotics
was illustrated by White et al. I96I. The increasing number of drug
combinations that became available for lay use only increased the
dairyman's e:)q)ense in his attempt to control this infection. The
loss of milk production was a major factor in the total cost of
mastitis to the dairyman. The greatest loss of milk has been shown
to be the result of subclinical staphylococcic infection. A recent
study (Wilson, I96I) indicated that subclinical infection caused
2nearly three times the loss in milk that was seen as a result of
the clinical form of mastitis. It became apparent that in order
to significantly reduce losses from S. aureus mastitis it was im-
portant that protection rather than treatment be considered.
The purpose of this project was to evaluate the effect of
one type of staphylococcic vaccine in the prevention and treat-
ment of infected mammary glands of cattle.
REVIEW OF LITERATURE
The use of vaccines to produce immunity against mastitis was
not new. As early as 1937, observations were made on the effec-
tiveness of vaccination for staphylococcic mastitis in cattle.
Gwatkin (1937) reported no decreases in the incidence of the or-
ganism in infected quarters following intramuscular injections of
a bacterin.
During the same year, Minett (1937b) reported that intra-
maiamary and intramuscular injections of toxoid failed to eliminate
the staphylococcic organism from infected mammary glands. He
found no evidence of a toxin in the whey of milk from chronically
infected quarters, althoiigh he was able to demonstrate toxins in
the secretions of three cows with a gangrenous mastitis. Minett
(1937a), cormaenting on Gwatkin 's v/ork and his own observations,
asked the question, "If antitoxins are of value, why does a high
incidence of clinical mastitis occur in chronically infected cows
shortly after parturition when the antitoxin titers of colostrum
are high?" Later work by the same author (Minett, 1939) demon-
strated the value of a staphylococcic toxoid in preventing the
3systemic effects and reducing the local effects of experimentally-
induced attacks of mastitis in ewes. He noted that two injections
of the alum precipitated toxoid at intervals of three weeks gave
better immunity than one dose of the same toxoid, and reported the
aim precipitated vaccine superior to the unprecipitated product.
fiichou and Holstein (1941) observed a more rapid recovery from
acute mastitis when a two percent potassium alum toxoid was injec-
ted intramuscularly. They noted the disappearance of staphylo-
cocci from the milk in 16 of 22 cows and an improvement in the
quality of milk in cows with chronic mastitis. Richou and Holstein
(1944) continued their investigation by treating 60 cases of staph-
ylococcic mastitis v/ith a toxoid. They suimnari2;ed their results
as 45 recovered completely, two improved, and 13 no change. Fail-
ure in 13 cattle was partially attributed to the jpresence of mixed
infections
.
Murphy (1947) observed that, on the basis of evidence thus
far presented, a cow's resistance to infection of the udder could
not be increased by vaccination or other immunization procedures.
Further results of treating boTine staphylococcic mastitis
with a toxoid were summarized by Collinson (1949). Of approxi-
mately 200 affected cows v^ich made clinical recoveries, only 20
remained positive to cultiire. His method of vaccination involved
the subcutaneous injection of 3, 4, and 5 ml. of a S. aureus toxoid
at five to seven day intervals. The treatment was repeated in any
animal remaining positive at the end of two wseks and the dose in-
creased to 6, and 10 ml. of toxoid. The same time interval was
allowed to elapse between injections. Disposal of the animals
4still infected after this second series was recommended. It was
Collinson's conclusion that S. aureus toxoid should be administered
routinely in the treatment of clinical mastitis.
Brown (I960) has criticized Collinson's work on several points.
Brown cautioned that no controls were used, composite samples
rather than individual quarter samples were utilized, and the in-
fection was diagnosed from stained smears of incubated milic in-
stead of by bacteriologic isolation and identification of the or-
ganisms. The research might also be questioned on the basis that
the samples were taken by the owners in sterile vials supplied by
the veterinarian, and no serious attempt was made to differentiate
between contamination of the sample and actual udder infection.
Collinson himself wrote: "This report does not offer conclusive
evidence as it is not a completed experiment."
During the early 1950 's the French literature abounded with
reports of the use of toxoids to produce immunity against mastitis.
In general, it was found that subcutaneous or intramuscular injec-
tion caused an increase in the blood antitoxin titers. (Ramon
et al
. ,
1951; Ramon et al
. ,
1952a; Ramon ejt al.
,
1952b; Ramon
et al
. ,
1952c; Ramon et al
. ,
1953)* Various types of toxoids were
used. Ramon et al. {1952b) used a ten percent aliiminum hydroxide
precipitant. Ramon et al. (1952c) used killed suspensions of staph-
ylococci, and a killed suspension of staphylococci and streptococci.
Ramon et al. (1953) repeated the use of the killed suspension of
staphylococci, but also added killed coli bacillus and two percent
potassium alum to the toxoid. The best antitoxin response occurred
vrtien alum or aluminum hydroxide was added to the vaccine.
5Preliminary tests of a toxoid-bacterin against bovine staphy-
lococcic mastitis by Spencer ejt al. (1956) showed that subcutane-
ous iiijection of one to three doses would reduce the severity of
the subsequent induced disease. No evidence of protection ^vas
foxind in sheep using the same procedure. Only 16 vaccinated quar-
ters and five control quarters were used. Chronic infections sub"
sequently developed in nine of the 16 vaccinated quarters.
A bacterin-toxoid was used by Pearson (1959) for prophylaxis
and for treatment. Favorable results were reported for a period
of 21 months. The clinical incidence of mastitis and the number
of staphylococcic infected quarters were less in the vaccinated
animals than in the control group. Ko significant difference vias
found between the two groups, however, during the last nine months
of the experiment. Pearson concluded that revaccination every six
months was not sxafficient to maintain immunity. He suggested that
the protective value of the vaccine might decrease directly with
time, in spite of booster vaccinations.
Slanetz et al. (1959) and Slanetz (1959) presented data on
several groups of cattle which were vaccinated with a staphylo-
coccic toxoid and bacterin-toxoid. The 16 percent infected qixar'*
ter rate dropped to 14-1 percent in the toxoid group at the end
of the IB month test period. The control group's incidence in-
creased from 16.6 percent to 50 percent at the end of the experi-
ment. Seventeen attacks of uncomplicated mastitis occurred in
31 of the vaccinated animals, while nine control animals had 33
attacks. Of eight heifers that were vaccinated with the toxoid
before calving, only one developed staphylococcic infection.
Three of four control animals were positive for staphylococcic mas-
titis. Kg acute exacerbations were seen in the vaccinated cattle,
while ten cases occurred in the four control aniiiials. Similar re-
sults v/ere obtained with the bacterin-toxoid although the differ-
ences between the control and vaccinated groups were not so marked.
Slanetz concluded that vaccination resulted in the production of
antibodies and increased resistance of cattle to staphylococcic
mastitis. Spread of the infection was almost completely prevented
in the vaccinated cattle and there was a marked reduction in the
nuiaber of acute flare-ups over the 13 month test period. Vaccina-
tion did not result in the recovery or elimination of the infec-
tion in quarters with well established chronic infections. Follow-
ing challenge with virulent staphylococci via the teat canal,
vaccinated cows developed only mild reactions of short durations
while severe acute reactions developed in nonvaccinated cows.
Chronic infections often became established in the challenged
control cattle.
Attempts to produce immunity against staphylococcic mastitis
in sheep by repeated intramuscular injections of mixed bacterin
were unsuccessful (Fillet et al., 1959a). The mixed vaccine was
then injected into the mammary tissue through the teat duct three
or four times at four day intervals. This method protected against
intramanuaary challenge one to three weeks after vaccination. A sub-
sequent report (Fillet et al
. ,
1959b) showed that this protection
decreased markedly diiring the first month and ceased 4^ days after
the last vaccination. A single booster dose given when immunity
had decreased considerably induced high resistance. The effect
7was foiind to be less via the intramuscular route than when the
vaccine was injected into the udder.
Further clinical evaluation of the Slanetz vaccine was under-
taken at one of the veterinary colleges (Fincher et al
. ,
I96O).
Two 5 ml. doses of the vaccine were given one month apart to in-
fected and normal cows in five herds. A summary of the first
year's results indicated that the product did no harm, produced
no change in the incidence of mastitis, and caused the cases that
did occur to seem less severe and less damaging to the udder.
The vaccine was found to be of no value in cattle with advanced
mastitis. Herds that were well managed got along very well af-
ter the vaccine was used; however, these herds might also have
done well if the vaccine were not used. Mo control animals were
available
.
Another survey, involving one herd over a period of three
years, revealed a S. aureus incidence of 20 percent the first
year, I6 percent the second, and seven percent the third year of
vaccination with the Slanetz toxoid (Hodges, I96O). It was not
certain whether this reduction occurred as a result of vaccina-
tion or because of improved management.
A mixed bacterin containing S. aureus
.
Streptococcus ag:alac-
tiae and Escherichia coli was used in six problem mastitis herds
by Stevens (I96O)
.
A 25 ml. dose was given subcutaneously and re-
peated in seven to 14 days and thereafter at six month intervals.
The udder changes due to mastitis were significantly reduced in
the vaccinated animals and the clinical incidence of mastitis was
three times greater in the control animals than in the vaccinated
cows. Vaccination v/as most effective in cattle with little or no
udder pathology and in those with infections that had not becorae
well established. Frequent injections of the bacterin proved
helpful in non-responsive individuals.
According to Blood et al. (i960) field experience with auto-
genous bacterins indicated that in some herds there was no apparent
protection, while in others, good protection was obtained. Acute
flare-ups of mastitis were reported as occurring following vacci-
nation in aniiaals apparently sensitized by previous infection.
Derbyshire (I96O) reported that vaccination with an alurainua
hydroxide gel precipitated vaccine stiraulated higher staphylococcic
antibody levels than did the formalized vaccine, the use of cells
alone, the toxoid, or whole culture. A higher degree of immunity
was also seen with the use of the gel vaccine in goats and cows
against intramararaary challenge in the living staphylococci. Pre-
liminary results indicated that the immunity against strains of
staphylococci other than that used in the vaccine was not as good
as that against the homologous strain.
In an excellent review by Brown (1960), the following conclu-
sions were enumerated by the author. Natural antitoxins had little
or no value in preventing udder infections. More information was
needed to determine the apparent greater protection seen with the
injection of toxoid. Blood antitoxins had some value in the pre-
vention of clinical mastitis by reducing the severity of experi-
mental infections and simple attacks in natural infections. Little
evidence was available to support the thought that antitoxins had
any value in eliminating existing staphylococcic infections.
fAn extremely interesting point was raised by Derbyshire
(1961a) concerning the possible inmunity resulting from toxoid
administration. He stated that there was no evidence that tox-
oids have any therapeutic value. Toxoids did stimulate antitoxin
function that afforded protection against certain strains of staph-
ylococci. But even with these strains only limited protection
was possible because staphylococcic antibodies in healthy cows
do not pass through the mammary epithelium. They exerted their
activity in the udder only at parturition and at the end of lac-
tation. A later paper (Derbyshire, 196lb) concluded that vacci-
nation of goats with strains of staphylococci resulted in a high
level of immunity to mammary challenge with homologous strains,
but not against heterologous strains of staphylococci.
During the past two years, interest in vaccination for mas-
titis has become widespread. Articles have appeared in lay journals,
the general attitude of which has been summarized by Guthrie (I96I).
He has pointed out that research indicated that vaccination softened
the impact of organisms capable of infecting the udder. It did not
always prevent their activity nor prevent infection from spreading.
Vaccination was not recommended until further research was done.
An experiment conducted at the University of Wisconsin showed
that cattle vaccinated with a staphylococcus bacterin-toxoid were
m>re resistant to mammary infusion with the vaccine strain of
staphylococci (Blobel et al.
,
1962a). Heterologous strains resulted
in a more severe udder reaction, although some protection was also
seen against these strains of organisms. It was concluded that
antitoxins present in the blood stream appeared to reduce the
,*.•>'
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severity of clinical loastitis. The results of this experiment
were also reported in a bimonthly professional magazine which in-
correctly stated that the vaccinated cattle "exhibited an increased
resistance to mammary infections with the homologous, but not to
those with the heterologous staphylococcic strains " (Blobel
et al. , 1962b)
.
In a second article on staphylococcic antitoxins in dairy
cattle, Brown (1962a) showed that the blood antitoxin and agglu-
tinin titers increased as the number of infected quarters in-
reased in cows with chronic staphylococcic mastitis. These
changes seemed to range within a certain level for each individual.
It was foxind that cows continued to become infected even though
there was an apparent increase in titer with the increased number
of affected quarters. He concluded that more information was
needed and that factors other than blood antitoxins and agglu-
tinins should be considered in studying the resistance of cows to
staphylococcic udder infections. In a later article, Brown (1962b)
reported that 17 of 20 cases of mastitis developed during the
first lactation or during the first two weeks after calving.
While vaccination had shown some promise, he cautioned that it
should not be expected to alleviate all cases. Systemic attacks
and death have occurred even thoxigh antitoxins were present in the
blood of the cow. The high incidence of mastitis during the first
lactation and shortly after parturition indicated that that peri-
od should be included in any vaccination program.
A final siimmation of the "vaccination-for-mastitis" question
has been provided by Gibbons (I962). He stated that the use of
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toxoids and bacterins seemed to be a practical method of control,
but that they were not effective in treatment. The use of bacte-
rins has definitely reduced the incidence or percentage of cases
of mastitis. "The initial vaccination should be repeated in two
to three weeks and every three months for the best results, keep-
ing in mind that sanitary milking practices and any other means
of mastitis control must be maintained at an effective level."
^' MATERIALS AND METHODS
_
.
Two dairy herds were chosen from the area surrounding I^Ian-
hattan. Each consisted of a significant number of animals, and
each herd had a history of a severe mastitis problem. In both
herds S. aureus was by far the most common pathogen isolated from
milk samples taken before the experiment was begun.
Herd A consisted of a total of 40 cows during the experimental
period. Of these, four were sold during the coiirse of the project
because of disease. Two were sold because of chronic attacks of
mastitis. One was disposed of because of sterility and the fourth
because of an attack of traumatic reticuloperitonitis . Thus, half
of the cows sold from Herd A were disposed of primarily because of
mastitis.
Herd B had a total of 113 cows on the experiment. Thirty-
five were sold during the experimental period because of disease
problems or old age. Of these cattle, 12, or 34.3 percent were
sold because of mastitis. The remaining cattle were disposed of
because of low milk production ("culls"), 15; reproductive problems,
four; old age, two; bad disposition, one; and traumatic reticulo-
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peritonitis, one. While these 12 cows represented a lower per-
centage of the total cows sold than occurred on Herd A, it was
nevertheless too high a percentage for an efficient operation.
Owners of both herds were contacted and agreed to cooperate
fully in the experiiuental use of a toxoid vaccine to attempt to
reduce the severity of their mastitis problem. It should be em-
phasized that the use of the vaccine was the only change that was
intentionally made in either herd program. No recommendations or
siiggestions were made to help improve the management or milking
procedures. It is difficult, however, to estimate how much effect
the periodic visits to the farms had upon the management. If any-
thing, one could safely say that the ov/ners certainly became more
disease conscious and more aware of their mastitis problem.
Vaccine Used
The product used to immunize Herd A and B against mastitis
was a purified concentrate of whole cultures of S. aureus that had
been inactivated with beta-propiolactonel. A total of 101 strains
of the organism isolated from clinical cases of mastitis, includ-
ing phage type 42D, were included in the vaccine. According to
Eeid et al. (1959) phage type 42D was one of the strains of
§L- aureus most frequently associated with clinical attacks of
mastitis. Fleming (I960) listed phage type 42D as one of the pre-
dominant types seen in mastitis. The vaccine consisted of cellu-
lar antigens from these strains of staphylococcic and standardized
quantities of beta and alpha toxoid. Inclusion of specific con-
Staphoid A-B, Jensen-Salsbery Laboratories, Inc.
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centrations of alpha and beta toxoid was based on a report by
Fleming et al. (1961). Of 101 isolates from clinical cases of
bovine mastitis, all produced alpha toxin, vdiile 56 percent pro-
duced beta toxin. Beta-propiolactone was used as the inactivat-
ing agent as it had several advantages over formaldehyde (Fleming,
I960)
.
Vaccination Procedure
A minimum of two samples were obtained from each animal be-
fore vaccination was performed in order to establish the "normal"
flora of the udder for each individual. In Herd A, this base pe-
riod before vaccination varied from two to six and one half months,
with the appropriate number of monthly milk samples taken from each
cow. In Herd B, two samples were taken from each cow before vac-
cination was started.
Since Herd A consisted of a relatively small number of cows,
the base period was used as the control period and all cows were
vaccinated. Following the cleansing of the area with an alcoholic
solution of a quaternary-ammonia corapoxmd, a dose of 5 ml. of the
vaccine was administered intramuscularly into the gluteal region
of the cows. The procedure was repeated at the end of six weeks
as was recommended by the manufactvu-er at the time the experiment
was started. (This recommendation has since changed to recommend
booster vaccination at two weeks.) Following the first two in-
oculations the vaccination was repeated at six month intervals.
The records that were available in Herd A made it desirable
to select this herd to test the therapeutic effect of the vaccine.
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Thirteen cows from this herd were selected on the basis of chronic
and reciirring mastitis attacks. These animals also had a high av-
erage number of infected quarters per cow. These animals were
given multiple injections of therapeutic doses of the vaccine.
Doses of 10, 15, and 20 ml. vrere administered every week for three
injections. Because of the quantity of material to be injected,
the "hamstring" muscles (semimembranosus, semitendiosus, and biceps
feraoris) were selected as the area of administration.
Herd B consisted of a larger number of cattle with well doc-
umented histories available for each animal. The herd was divided
into a control group and a vaccinated group, attempting insofar as
was possible to place an equal nmber of individuals with the same
ages, history of mastitis, and previous milk production in each
group. The animals were also equally divided on the basis of
number of infected quarters, based on the samplings that were taken
during the base period (Brown, I960). The vaccinated animals were
injected with 5 ml. of the vaccine in the gluteal muscles, follow-
ing the preparation of the skin as described in Herd A. This was
repeated in six weeks and every six months during the course of
the experiment. The control animals were also injected at the
same time with a placebo prepared by Jensen-Salsbery Laboratories,
Inc. The owner was not advised that a control group was being em-
ployed. Positive identification of the cattle was by the use of
large aluminum ear tags which could be read from a practical
distance. Heifers coming into the milking herd were alternately
designated as vaccinates or controls. These animals %rere vacci-
nated immediately after the first milk sample was taken, and only
15
one base period milk sample was available on the newly introduced
animals.
The owners of each herd were supplied with a written form
that was used to record clinical cases of mastitis. The form
contained spaces for the cow's number, date of the attack, and
the quarter affected. All mild attacks were recorded by the own-
ers in this manner. It was requested that the clinician be called
to treat any attacks of mastitis in which the cow was showing
systemic signs. During the monthly sampling visits to the herds,
the forms were collected and new ones supplied.
Sampling Procedure
Milk samples were collected from each cow on the experiment
on a once-a-month basis, as nearly as was practical for the own-
ers and the writer. All animals were sampled except for the rare
cow that was dry and had been turned onto pastiire. Cattle that
were not milking but were still in the milking herd were also
sampled
.
The owners were instructed to follow their usual milking pro-
cedure. This involved the restraint and feeding of concentrates
to the cattle to be mi3Jced, and the v/ashing of the mammary glands
with a sponge and warm water. Herd A employed the use of a
chlorine compound as disinfectant, while Herd B used a soap base
quaternary-ammonia solution. As stated earlier, no conscious
attempt was made to influence the milking procedures.
Following the cleansing of the udder by the owner, samples of
milk were aseptically collected from each quarter in individual
\sterile tubes. This was accomplished by the cleansing and wiping
of the teats and teat openings with cotton satiirated with an alco-
holic solution of a quaternary-ammonia compound. The cotton was
squeezed slightly before use so that there was little danger of
having a drop of the antiseptic on the teat orifice when the milk
sample was taken. One piece of cotton was used for all four teats.
The teats were cleaned in a systematic fashion, so that the hand
of the operator v/ould not be carried across the teats that had al-
ready been cleansed. This involved cleaning the teats furthest
away first and working toward the milker, then collecting the milk
from the nearest teats first and working away from the milker.
The first milk available was collected, and no more than one or
two strippings of the teat were permitted in order to reduce con-
tamination of the sample to the minimum. One to ^ ml. of milk were
collected. The tubes were identified with the cow's number in order
of milking and the quarter. A master sheet clarifying which quar-
ter from which cow was being collected in what tube was made at
the time of collection.
The milk samples were returned to the laboratory as soon as
practical and placed under refrigeration until the agar plates
were streaked.
Laboratory Examination
All samples were refrigerated before culturing to reduce the
growth of any contaminates that might be present.
Each milk sample was streaked on a sheep blood agar media in
a petri plate. All four qxaarter samples from one cow were cul-
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tured on the same plate. The plate was incubated for 24 hours in
an inverted position at 37 °C. Following this period the plates
were examined and the organisms present identified and recorded.
Brown (I960) implies that this is a necessary procedure for the
identification of infected quarters. All colonies that were sus-
picious of being S. aureus were tested for coagulase activity
(Fleming et al
. ,
1961; Reid et al. , 1959). Organisms that were
positive for coagulase were recorded. Plates that were complete-
ly negative after 24 hours were incubated for another 24 hours and
reexamined.
For a period of time incubated methylene blue stained milk
smears of the individual quarters were also examined to determine
infected quarters. However, since this examination of smears was
not performed all through the experiment its results v/ere unable
to be correlated for both the base period and test period. Con-
sequently results of the examination of incubated stained milk
smears were not taken into consideration in this thesis.
A total of 19 herd milk samplings and cialtures were performed
on Herd A over a period of 19^ months. Herd B was surveyed for
14 months during which 11 milk samplings and cultures were con-
ducted .
. ,
Recording of Clinical Attacks and Culture Results
A special book was prepared for each herd and a page on this
book was assigned to each animal in the experiment. On each page
the results of the monthly milk samplings and cultures, and the
attacks of clinical mastitis (with the date and quarter affected)
1&
were recorded chronologically. Any treatment or illness that
occurred in the herd and on individual animals was also noted.
Ciiltural results were recorded as they were read in the lab-
oratory. In the recording of the incidence of infected quarters
only the quarters infected with S. aureus vfere tabulated. Since
the vaccine being used was specific for this organism, it was felt
that its effect against the intended victim should be particular-
ly noted.
RESULTS AND DISCUSSION
The vaccination of all the cows in Herd A complicated the
evaluation due to the lack of a control group. Because of this,
the effect of vaccination on Herd A was evaluated by comparing
the long base period with the test period. Herd B was analyzed
by the comparison of the vaccinated and control group of animals.
The herds were evaluated on the effect of the vaccination on the
clinical incidence of mastitis, the effect of vaccination on the
incidence of infected quarters, the therapeutic effect of vacci-
nation on chronically infected cattle, and the side effects of the
vaccination procedure.
Effect of Vaccination on the
Clinical Incidence of I-lastitis
The clinical incidence of mastitis was computed on the basis
of attacks per cow month (CM) . A cow month was considered as one
cow being on the experiment one month.
The clinical incidence of mastitis in the 3^ cows of Herd A
during the base period and test period is presented in Table 1.
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A total of 212 cow months were involved diiring the base period,
vhile 444 cow months were present in the test period. Fourteen
cows had no attacks during the experiment. Eleven cows had at-
tacks of mastitis during both periods.
Table 1. Clinical incidence of mastitis attacks in Herd A during
base period and test period.
' Base period : Tftflt. pftrind
: Cows: Attacks; CM per attack : Cows : Attacks : CM per attack
Mastitis 17 40 5-3 19 51 ^-7
MiS Xtis
with corap.* 1 1 212.0 2** 3 146.0
No attacks 20 iB
* Mastitis with systemic complications.
** Also had attacks of mastitis.
Although the number of cow months required per attack of mastitis
increased for both types of mastitis, this increase was not sta-
tistically significant. Thus there was no significant difference
in the clinical incidence of mastitis in Herd A following the
vaccination.
It was interesting to note that of the 14 cattle that had no
attacks of mastitis during the experiment all were four years of
age or younger at the start of the test. Of the 11 cattle that
had attacks in both the base and test periods only two were under
four years of age at the start of the project.
All three of the cows that had attacks of mastitis with sys-
temic complications were older cattle. Two were six and one-half
20
years old at the start of the experimental period. The other cow
was four and one-half years old when the experiment began.
It appeared that even with vaccination, the attacks of mas-
titis were by far more common in older cattle. As the cow's age
increased, so did the incidence of mastitis. In the 24 cows that
were four years of age or yoimger at the start of the experiment,
24 attacks of mastitis were seen. The 16 cattle that were over
four years of age at the beginning of the experiment had 6? at-
tacks of mastitis and four attacks of mastitis with systemic
complications.
In attempting to evaluate any product against mastitis, the
Age of the cattle should be taken into consideration, and if a
control gretap is used an equal number of the sane ag«d cows should
be placed in the treated and control groups.
The clinical incidence of mastitis in Herd B is presented in
Table 2. The base period consisted of one month, while the test
period was 13 months. The herd consisted of a total of 113 cows.
Forty-six cows had no attacks of mastitis during the experiment.
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Table 2. Clinical incidence of mastitis attacks in controls and
vaccinates of Herd B during base period and test period.
Base period
t :Mas- : CM ;M.W. ;comp,
t :titis: perrC* : **
: CM : tacks : tack : tacks : tack
Teat period
:Mas- : CM :M.W.
:titis: per:C.
CM : tacks: tack: tacks
CM/
comp.
attack
Con-
trols
Vacci-
nates
Herd
total
54 10 5-4 54+ 32S 52 6.3 3 109-3
4S 11 4 4 4^+ 363 53 6.8 363+
102 21 4-9 102+ 691 105 6.6 3 230-3
* Mastitis with complications
CM per complicated attack.
While there was a general increase in the number of cow months
required for an attack of mastitis, this increase was present in
both control and vaccinated cattle. The difference between the
two groups was not statistically significant, although a slightly
larger number of cow months per laastitis attack was required in
the vaccinated group than in the control group. Vaccination had
no significant effect upon the incidence of clinical mastitis in
Herd B.
Of interest was the fact that seven of the eight cows in the
control group that were sold for mastitis were four years of age
or older at the start of the experiment. Nine of the 25 cows in
the group with mastitis were four years of age or older when the
experiment was begun. Of 11 cows that had two or more mastitis
attacks, seven were four years or older at the beginning of the
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project. Two of the three attacks of mastitis with systemic com-
plications occurred in cattle over four years of age.
All four of the vaccinated cattle that were sold because of
mastitis were over four years of age at the beginning of the pro-
ject. Seven of the 19 cows that had mastitis attacks were at
least four years of age when the experiment began. Seven of the
,-'':»-•
11 COWS with two or more attacks of mastitis were four years of
aga or older in the beginning of the experiment.
In Herd B 11 of the 12 cows sold because of mastitis wera
over four years of age. Sixteen of the 44 cows having mastitis
attacks were four years or older when the experiment was started,
while 14 of the 22 cattle having two or more attacks of mastitis
were at least four years of age when the project began.
When it was realized that of the herd of 113 head only 50
cows were four years of age or older when the experiment was
started and that 11 of the 12 cattle sold for mastitis were over
this age, the effect of age on the incidence of mastitis became
more significant. While 63.6 percent of the cattle in the group
that had repeated attacks of mastitis was four years of age or
older, only 44-2 percent of the entire herd was of this age group.
If protection against mastitis could have been established be-
fore infection of the cow had occurred, it would be interesting to
speculate what the incidence of mastitis for each age group would
have been.
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Effect of Vaccination on the Incidence
of Infected Quarters
In order to study the effect of vaccination on the incidence
of infected quarters, the results of bacteriological examination
of milk were recorded. In the analysis only those quarters that
were infected with S. aureus were considered as positive. The
' evaluation was based on the average number of infected quarters
per cow for the periodic milk samplings
.
The results of repeated milk cultures during the base period
ilid test period of Herd A are presented in Table 3- The base
period included the sampling that was obtained at the time of the
first vaccination.
Table 3 • Average number of infected quarters per cow of Herd A during base
period and test period.
• Base period : Test period
: Mo. of monthly "samplings ; : No . of monthly samplings :
; 3 : 2 ; 2 : 2 : At. ; 3 : 2 ; 2 : 2 : Ay.
No. of cow
samples 75 69 ^ f| 100 51 ^ 52
No, inf. qrs. 97 63 71 100 109 73 113 39
Inf. qrsVcow 1-30 0.91 1.00 1.23 1.12 1.09 1-43 1-41 1-71 1-41
In spite of the vaccination procedure there was a gradual rise in
the average number of infected quarters per cow.
Thirteen of the cows in Herd A were treated for mastitis with
large quantities of vaccine during the process of the experiment
(see the following section). It was, therefore, necessary to com-
pare the treated and untreated animals to be certain that the re-
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suits just presented were not affected by this procedure. This
comparison is presented in Table 4«
Table 4- Average number of infected quarters per cow of the treated and
untreated cattle in Herd A during base period and test period.
Base period Test period
No. of monthly samplings: :No. of monthly samplings
: Av.2 : 2 : 2 : Av. : 3 : 2 : 2 : 2
Treated cows
No. of cow tr 25 24 25 36 23 27 19
samples
5«No. inf. qrs. 31 29 35 51 39 50 46
Inf. qrs./cow 1.15 1.16 1.46 1.96 1.43 1.61 1.70 1.85 2.42 i.ao
Untreated cows
No. of cow 444 47 52 64 5^ 33
samples
34 36 49No . inf . qrs
.
66 51 34 63 43
Inf. qrs. /cow I.3S 0.77 0.77 0.94 0.97 o.ao 1.21 1.19 1.30 1.13
Both treated and untreated groups demonstrated a gradual rise in
the average nvuaber of infected quarters per cow during the experi-
ment. This was similar to the increase seen throughout the herd.
The treated group had a relatively higher average number of infected
quarters throughout the experiment because these cattle were selected
for a high number of infected quarters.
There appeared to be a wide variation of incidence of infected
quarters in this herd and its relationship to the clinical attacks
of mastitis.
Cow 45 had only two positive qiiarters from a total of 17 samp-
lings and a possible 68 infected quarters. Cow 49 had only three
positive quarters out of a possible 68. These cattle had 0.12 and
0.18 average iafected quarters during the experiment. This was
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about one-tenth the herd average of 1.26. It was no surprise that
these cattle did not have any attacks of mastitis during the en-
tire 192 months of the experiment. Nor was it any surprise that
cow 5, with only three infected quarters during the testing period,
had only one attack of mastitis.
It might be anticipated that cattle with a moderate number
of infected qiiarters should have had an average number of clinical
attacks of mastitis. Cows 8 and 44 illustrate some of the average
statistics that were found. Both had 11 infected qiiarters during
the experimental period. These cattle had one and three attacks
of mastitis, respectively.
As was true of the first cattle cited, cows 12 and 13 also
had a low incidence of infected quarters; but in these cattle a
high rate of clinical mastitis was seen. Cow 12 had an incidence
of 0.75 average infected qxiarters over the base period and 1.75
during the test period. This is in contrast to her groups average
of 1.43 and l.BO infected qviarters per cow for the same periods.
Yet cow 12 had four attacks of mastitis during the base period and
seven attacks during the test period, for a total of 11 mastitis
attacks. The average number of attacks for this cow's group was
Cow 13 gives a similar pattern. Her average number of in-
fected qxiarters during the base and test periods were 1.29 and
1.00, respectively. She had a total of seven attacks of mastitis
during the two periods.
Cows 10 and 3^ are the converse of the first examples cited.
Cow 10 had figures of 3*33 and 3.B0 for the average number of in-
fected quarters during the base period and test period. Her group's
2^
respective average figiires were 0.97 and 1.13. However, cow 10
had only foiir attacks of mastitis. Cow 3& had 37 infected quar-
ters out of a possible 76, and yet only one simple case of mastitis
developed.
There was also the cow that appeared to be resistant to mas-
titis and yet became severely affected in a short period of time.
Of a possible 44 quarters, cow 9 was found infected in only four.
Yet over the experimental period she had three attacks of mastitis
and one with systemic complications. Three of the attacks took
place during the last two months of the test period. She was
finally so severely affected with mastitis that one teat had to be
amputated. Two of the remaining qiiarters abscessed and the animal
was sold shortly thereafter.
It was extremely difficult to predict the incidence of clinical
mastitis in any one cow merely on the basis of that cow's average
number of infected quarters.
The average number of infected quarters per cow in Herd B were
evaliiated on a monthly basis. The sample taken at the time of the
first vaccination was considered as part of the base period, the
other nine falling into the test period. The monthly and periodic
incidence of infected quarters in the control and vaccinated ani-
mals in Herd B are presented in Table 5 •
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Table 5. Average number of infected quarters per cow in the control and
vaccinated animals of Herd B during base period and test period.
: Base period : Test period
: Monthly : :
Monthly samplings
•
•
: samplings : Av .
:
:Av.
Controls
No. of
cows 14 S6 46 41 40 31 31 21 24 22 IB
No. inf.
qrs. 3# 4a 53 52 6l 32 30 4^ 27 53 40
Inf. qrs./
cow 0.63 1-11 0.87 1.15 1.27 1.53 1.03 0.97 2.39 1.13 2.64 2.22 I.46
Vaccinates
Ko. of
cows ii 49 51 44 44 37 37 29 27 24 21
No. inf.
qrs. 20 55 54 54 54 26 23 33 23 64 45
Inf. qrs./
cow 0.42 1.12 0.77 1.06 1.23 1.23 0.70 0,62 1.14 1.04 1.67 2.13 1.21
Herd total
No. of
cows 102 105 97 35 84 68 68 50 51 46 39
No. inf.
qrs. 55 117 107 IO6 115 58 53 81 55 122 85 .
Inf. qrs./
cow 0.54 1.11 0.83 1.10 1.25 1.37 0.85 0.78 1.62 1.06 2.65 2.18 I.32
In both the control animals and the vaccinated group there was an
increase in the average number of infected quarters per cow during
the course of the experiment. Although both groups started out
with no statistically significant difference, at the end of the
test period the difference between the control and vaccinated cattle
was significant (Chi square = 10.428 with 1 degree of freedom).
2a
The vaccination of cattle in this herd resulted in a statistically
significant smaller increase in the average number of infected
quarters per cow v/hen compared with that of the control cows.
It was also interesting to observe the wide variation in
correlation between the incidence of clinical attacks and the
number of infected quarters of certain cows in Herd B. While not
quite as striking as the variation seen in Herd A, it neverthe-
less was difficult to predict a cow's incidence of clinical in-
fection on the basis of her average number of infected qiiarters.
Only one cow in Herd B did not have any infected quarters
during the experimental period. She v/as sampled on eight occasions
during this time. This cow had no clinical attacks of mastitis.
As might be expected, several cattle afflicted v/ith numerous
attacks of mastitis also had a high average number of infected
quarters. Cow 69 had an average of 2.2 infected quarters during
the experiment, and had nine attacks of mastitis. Cow 46 had an.
infected qiiarter average of 1.6 and had ten mastitis attacks. Cow
5 had 11 attacks and had an average of 2.1 infected quarters dur-
ing the course of the experiment. The infected quarter average
of the herd was 1-32.
,
'
"
Some cattle had an above average incidence of infected quar-
ters but had few attacks of mastitis. Cow 6 had only one attack
but had an infected quarter average of 1.5. Cow 36 had an average
of 2.5 and did not have a single attack of mastitis.
There was also cattle that had a low infected quarter average
and yet had a severe mastitis problem. Cow 45 had an average in-
cidence of only O.a infected quarters, and yet she had three at-
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tacks of mastitis and was so severely affected that she had to be
sold. Cow 71 also had a severe mastitis problem and had to be
sold. She had an average incidence of only O.B infected quarters,
but had six attacks of mastitis before being disposed of.
The use of large doses of intramaramary antibiotics in Herd B
may have been a factor in explaining the closer correlation be-
tween the ninaber of clinical attacks and the incidence of infected
quarters. Herd A did not use any antibiotic therapy. It was
possible that the antibiotic therapy reduced the incidence of in-
fected quarters so it more nearly correlated with the incidence of
clinical attacks.
Clinicians should be aware of the occurrence of these vari-
ations in the clinical and bacteriological incidence of mastitis.
Cattle having a low incidence of clinical mastitis and a high aver-
age niimber of infected quarters xnay well be the carrier animals that
have acted as "Typhoid Marys" in the dairy herd. It is hoped that
future clinical research will shed more information on this sub-
ject .
Therapeutic Effect of Vaccination
Following the treatment of 13 selected cows from Herd A with
therapeutic doses of vaccine, the records of these cows were com-
pared with the records of 2ll untreated cattle in the same herd.
These cattle were evaluated on the basis of clinical attacks of
-»- Six other xantreated cattle in Herd A were not included in
this evaluation because of a lack of complete records during the
base and test period.
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mastitis per cow month and average niomber of infected qxiarters per
cow. The milk sample collected at the time of the first treatment
was considered as part of the base period.
The comparison of the treated and xmtreated cows on the basis
of clinical attacks per cow month is presented in Table 6. The
average number of infected quarters per cov/ in the two groups is
presented in Table 7«
Table 6. Clinical incidence of mastitis attacks in treated and
untreated cows during the base period and test period.
1
t
CM
Base period
":1S's- :CI.I :M:W. :CM/
:titis:per :C.* :comp.
:at- :at- :at- : **
:tacks : tack : tacks :attack
:Mas:":C^^fCT. :CW
:titis: per :C. :comp.
lat*" zat"" zat"" lat*"
CM :tacks :tack : tacks :tack
Treated I36.O
Untreat-
ed
Herd
20g.5
344.5
52 2.6 2 68.0 100.5 10 10.0 1 100.5
14 14.9 1 208.5 178.5 13 13.7 208.5+
66 5.2 3 114.5 279.0 23 12.1 1 279.0
* I^stitis with complications attacks.
** Cow months per complicated attack.
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Table 7. Average nvunber of infected qiiarters per cow in the treated
and untreated aniioals dviring the base and test periods.
case period : Test period
No. of samplings •• :No. of samplings •
: 2 : 2 : 2 : Av. : 2 : 3 : 2 : Ay,
Treated 1.15 1.16 1.46 1.96 1.61 1.47 1.70 1.S5 2.42 1.99
Untreated 1.3^ 0.77 0.77 0.94 o.go 0.93 1.21 1.19 1.30 1.23
Herd 1.30 0.91 1.00 1.2g 1.09 1.12 1.43 1.41 1.71 1.52
Following the injection of therapeutic doses of the vaccine an
Increase in the number of cow months required for an attack of
mastitis was seen in the treated cows. The untreated animals main-
tained a relatively constant level of cow months per attack of
mastitis. The increase seen in the treated cattle was not sta-
tistically significant hov/ever. The average number of infected
quarters per cow increased in both the treated and imtreated
groups. There was no significant difference observed.
No significant therapeutic effect from the use of small quan-
tities of the vaccine was noted. The xmtreated group in Herd A
showed no significant change in the gradual increase in average
number of infected quarters per cow which had been occurring dur-
ing the base period.
The injection of small quantities of the vaccine in Herd B
had no therapeutic effect on the infected quarters. The incidence
of infected quarters per cow continued to increase in the vacci-
nated cattle as well as the control cows. The increase, however,
was smaller in the vaccinated cattle. It was thought that this was
32
due to a decrease in the rate of spread of the infection, rather
than to the alleviation of previously infected quarters.
Side Effects of the Vaccination Procedure
In a total of 3$ cattle in Herd A that were vaccinated
a minimum of three times with an intramuscular dose of 5 iul>
no serious side effects were noted. There was some initial
irritation apparent as expressed by uneasiness on the part of
the patient during the injection. Two cows had a mild swelling
for two to three days at the injection site.
In the 12 cows vaccinated with therapeutic doses of vaccine,
a mild irritant action occurred diiring administration. There was
swelling in only one animal and this rapidly subsided after three
days. Several days after the injection of 20 ml. of the vaccine,
this cow had a fibrosis at the site of the injection. No clin-
ical lameness or malfunction of the limb was apparent.
No degree of shock or allergic response due to repeated ad-
ministration was noted.
In a total of 113 cattle in Herd B that were vaccinated, no
serious side effects were noticed. A mild thickening and slight
swelling of the injected area was noticed in ten percent of the
cattle, but in all cases this subsided in three to five days.
This reaction was greater in the gluteal region than when the
thigh muscles were utilized. Two cattle showed unusual effects
from the second vaccination. One month after the booster vacci-
nation was administered the owner noticed swelling in the gluteal
region of one cow. It was 10-12 cm. in width when called to our
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attention. The swelling was lanced and 100 ml. of a thick yellow
material removed. The area was treated locally and healing was
uneventfiil. The other cow had a similar swelling, but it did not
appear xmtil two months after the second vaccination. Healing was
complete following lancing and local treatment.
It was difficiilt to explain these reactions without consider-
ing the possibility of induced infection at the time of vaccina-
tion. Ho reactions were seen in the animals injected with the
placebo. The possibility of the vaccine having been deposited in-
to an area other than the muscle (i.e., into or through the sacro-
sciatic ligament) must also be considered. The inactivating agent
that v^as used in the preparation of the vaccine could have pro-
duced necrosis at the site of injection. Bacteriological culture
of the abscesses was not performed.
It is recommended that products similar to that used in this
trial be injected into the large muscle masses of the animals body.
Large doses are not suggested. Proper injection technique is im-
portant to reduce the pain and tissue irritation, as well as to re-
duce the possibility of abscess formation. Recommended amounts in
the "thigh" muscles will resiilt in more rapid absorption, less
tissue reaction, and minimal pain to the patient during administra-
tion. Sterility of instrun^nts, product and equipment, and general
cleanliness aid in securing minimal post-vaccination reactions.
The use of vaccination procedures as a method of controlling
mastitis was of insignificant value. The lack of definite informa-
tion about other factors that influence mastitis control is obvious.
Future clinical research in this area is needed, as was well stated
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by Blobel and Miirphy in the following quotations.
"Until the factors which play a determinant role in ..
the ability of staphylococci to become established in the udder
and cause disease .. .have been properly identified, particularly
with respect to their immunologic significance, attempts at large
scale vaccination as a means to control staphylococcic mastitis
are likely to remain emperical and probably fruitless." (Blobel
et al.
,
1962a)
"It is to be hoped that .. .people. . .will see that only in
one of the four disease which comprise mastitis is there sufficient
knowledge on which to base a precise, sensible, general control
effort .... Until we make the tremendous effort needed to correct
this deficiency, the control of these other forms will remain in
the emperical, trial-and-error area supported at best by testi-
monials." (Murphy, 1956)
CONCLUSIONS
The vaccination of dairy cattle with a staphylococcus toxoid
resulted in a decreased clinical incidence of mastitis. This de-
crease was not statistically significant.
The clinical incidence of mastitis was shown to increase di-
rectly with the age of the cow. The period of four to four and
one-half years of age appeared to be critical. A much higher
incidence of mastitis was seen in this older group of cattle, t
Vaccination had no effect in halting the incidence of infected
quarters. A significantly slower rate of spread was noted in the
vaccinated cattle of one herd.
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The absence of a definite correlation between the incidence
of infected quarters and the clinical incidence of mastitis was
illustrated.
The treatment of chronically infected cows with large doses
of vaccine resulted in a decreased incidence of clinical mastitis.
This decrease was not statistically significant. There was no
effect on the incidence of infected quarters when cows were treated
with large quantities of the vaccine.
No serious side effects were noted from the routine admin-
istration or repeated injections of large quantities of the
vaccine. The use of the large muscles of the body, proper in-
jection technique, and sterile procedure are recommended.
Staphylococcus toxoid was found to be of limited value in
the control of mastitis. The need for fiirther researd into the
Ifactors which complicate mastitis control is indicated. ^
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Mastitis is the most costly disease of dairy animals in the
United States today. Of the various organisms that are capable
of causing mastitis Staphylococcus aureus is, perhaps, the most
troublesome. The purpose of this study was to evaluate a staph-
ylococcus toxoid as a prophylactic and therapeutic means of con-
trolling mastitis.
The available literature on the \ise of vaccination against
mastitis was not abundant and the majority was published during
the previous twenty years. Clinical reports involving large num-
bers of cattle and the use of control animals are uncommon. Much
of the literature was conflicting.
Two dairy herds were vaccinated with a staphylococcus toxoid.
All 3^ covjs in Herd A v/ere vaccinated, and selected cows with
chronic mastitis were treated with therapeutic doses of the pro-
duct. Herd B v/as divided into control and vaccinated groups, on
the basis of age, previous milk production, history of mastitis,
and number of bacteriologically infected quarters. As new addi-
tions to the herd v/ere made they were alternately divided among
the groups. A total of 1X3 cows were used in the experiment in
Herd B.
The vaccination procedure consisted of the injection of 5 ml.
of staphylococcus toxoid in the gluteal muscles. This was repeated
in six weeks, and booster injections were given every six months.
The cows treated in Herd A were given 10, 15 and 20 ml. of the
vaccine at weekly intervals. Monthly milk samples were collected
aseptically from both herds for periods of 19^ months in Herd A,
and 14 months in Herd B. The samples v/ere cultxired on sheep
2blood agar media and examined after 24 hours for evidence of bacter-
iological growth. Coagulase determinations were performed on all
organisms that were suspected of being S. aureus In the absence
of bacterial growth, reincubation for 24 hours and examination was
perfonned.
Daily records were kept by the owners of both herds of any
clinical attacks of mastitis. These were recorded on a special
form and transferred to the herd test record at the time of
monthly milk sampling. The results of bacteriological determina-
tion were similarly recorded.
Evaluation of the vaccination was based on its effect on the
clinical incidence of mastitis, the effect upon the incidence of
infected qixarters per cow, the therapeutic effect upon the chron-
ically affected cows and incidence of infected quarters, and the
side effects that were seen diiring the vaccination procedure.
Only those quarters infected with S. axireus were considered when
analyzing the incidence of infected qmrters.
Vaccination resulted in a slight decrease in the clinical
incidence of mastitis of both herds. This decrease was not sta-
tistically significant. Both herds exhibited a gradual rise in
the incidence of infected quarters following vaccination. The
increase was significantly less in the vaccinated animals of
Herd B \ihen compared with the control animals. Ko statistically
significant effect was observed due to the treatment of chronically
affected cattle with large doses of the vaccine. Similarly, small
doses of the vaccine had no effect on the bacterial flora of the
udder of cattle in both herds. No severe side effects were seen
due to the vaccination procedure.
The use of the vaccine as a means of controlling mastitis
was of limited value. The absence of information on factors that
would influence the mastitis problem was obvious. Further re-
search work in this area is necessary.
